Results

Total Results: 2,582 records

Showing results for "testing".

2541. Lung-Cancer-Nonsurgical-Therapies Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_executive.pdf
      June 01, 2013 - 1 Comparative Effectiveness Review Number 112 Local Nonsurgical Therapies for Stage I and Symptomatic Obstructive Non–Small-Cell Lung Cancer Executive Summary Background Non–small-cell lung cancer (NSCLC) refers to any type of epithelial lung cancer other than small-cell lung cancer.1 The disease arises f…

2542. Liver-Cancer-Therapy Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_executive.pdf
      May 01, 2013 - 1 Local Therapies for Unresectable Primary Hepatocellular Carcinoma Executive Summary Introduction Background This comparative effectiveness review evaluates local hepatic therapies for patients with unresectable primary hepatocellular carcinoma (HCC) who are not candidates for surgical resection or liver tr…

2543. Identifying Priorities for Patient-Centered Outcomes Research for Serious Mental Illness (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/mental-illness-priorities_research.pdf
      September 01, 2011 - Identifying Priorities for Patient-Centered Outcomes Research for Serious Mental Illness Research White Paper Identifying Priorities for Patient-Centered Outcomes Research for Serious Mental Illness Research White Paper Identifying Priorities for Patient-Centered…

2544. DEcIDE 33: Summary Variables in Observational Resesarch: Propensity Scores and Disease Risk Scores (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
      May 01, 2012 - DEcIDE 33: Summary Variables in Observational Resesarch: Propensity Scores and Disease Risk Scores Research from the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Network May 2012 Effective Health Care Program Research Reports Number 33 Summary Variables in Observational Research: Prop…

2545. Infantile-Hemangioma Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
      January 01, 2016 - 1 Comparative Effectiveness Review Number 168 Diagnosis and Management of Infantile Hemangioma Executive Summary Introduction Infantile hemangiomas (IH) are the most common tumors of childhood. IH are benign but possess potential for local tissue damage, ulceration, infection, bleeding, functional impact, and…

2546. Untitled (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/pelvic-pain-surveillance-151130.pdf
      July 10, 2015 - Untitled AHRQ Systematic Review Surveillance Program CER #41: Noncyclic Chronic Pelvic Pain Therapies for Women: Comparative Effectiveness Original Release Date: Jan…

2547. Hepatitis-C Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c_executive.pdf
      November 01, 2012 - 1 Comparative Effectiveness Review Number 76 Treatment for Hepatitis C Virus Infection in Adults Executive Summary Background Hepatitis C virus (HCV) is the most common chronic bloodborne pathogen in the United States. HCV is primarily acquired by large or repeated percutaneous exposures to blood, with …

2548. Making Healthcare Safer IV_Rapid Response_Deprescribing To Reduce Medication Harms in Older Adults (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-deprescribing.pdf
      February 01, 2024 - Making Healthcare Safer IV_Rapid Response_Deprescribing To Reduce Medication Harms in Older Adults Making Healthcare Safer IV Deprescribing To Reduce Medication Harms in Older Adults Rapid Response Main Points • Deprescribing has emerged as a clinical practice to reduce polypharmacy and use of potenti…

2549. Protocol for Quantitative Assessment of Benefit and Harm analysis of Aspirin for primary prevention (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research.pdf
      February 01, 2014 - Protocol for Quantitative Assessment of Benefit and Harm analysis of Aspirin for primary prevention Methods Research Report Evaluation of the Benefits and Harms of Aspirin for Primary Prevention of Cardiovascular Events: A Comparison of Quantitative Approaches …

2550. Dental Care for People With Hemophilia: A Rapid Response Literature Review (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hemophilia-dental-rapid-response.pdf
      July 01, 2024 - Dental Care for People With Hemophilia: A Rapid Response Literature Review Rapid Response May 2024 Dental Care for People With Hemophilia: A Rapid Response Literature Review Main Points • A search of the Embase® and PubMed® databases, as well as professional society websites, identified no primary research stu…

2551. Layout 1 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_executive.pdf
      September 01, 2011 - Layout 1 Background Antipsychotics medications are approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia and bipolar disorder. These medications are commonly divided into two classes, reflecting two waves of historical development: the conventional antipsychotics and the atypical. T…

2552. Restless-Legs Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
      November 01, 2012 - 1 Comparative Effectiveness Review Number 86 Treatment for Restless Legs Syndrome Executive Summary Introduction Restless legs syndrome (RLS) is a neurological disorder characterized by unpleasant sensations in the legs and a distressing, irresistible urge to move them. RLS can result in reduced quality o…

2553. Glaucoma-Treatment Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_executive.pdf
      April 01, 2012 - 1 Comparative Effectiveness Review Number 60 Treatment for Glaucoma: Comparative Effectiveness Executive Summary Background Glaucoma is a leading cause of visual impairment and blindness both in the United States and worldwide. It is estimated to affect 60.5 million people worldwide.1 Glaucoma is defined as…

2554. Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
      March 01, 2024 - Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments Rapid Evidence Product Adverse Events Associated With COVID-19 Pharmaceutical Treatments Background and Purpose The purpose of this rapid review is to determine if COVID treatments authorized for emergency use…

2555. Comparative Effectiveness and Safety of Analgesics for Osteoarthritis—An Update of the 2006 Report. (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-disposition-120516.pdf
      October 01, 2011 - Comparative Effectiveness and Safety of Analgesics for Osteoarthritis—An Update of the 2006 Report. Source: http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and- reports/?productid=494&pageaction=displayproduct Published Online: August 2010 Comparative Effectiveness Research Re…

2556. Insulin Delivery and Glucose Monitoring Methods: Future Research Needs (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar_research.pdf
      August 01, 2015 - Insulin Delivery and Glucose Monitoring Methods: Future Research Needs Future Research Needs Paper Number 32 Insulin Delivery and Glucose Monitoring Methods: Future Research Needs Future Research Needs Paper Number 32 Insulin Delivery and Glucose Monitoring Methods: Future Research Needs Identification …

2557. Dietary-Supplements Surveillance (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
      January 01, 2013 - CER #51: Dietary Supplements in Adults Taking Cardiovascular Drugs Original release date: April, 2012 Surveillance Report: April, 2013 Key Findings: - A small number of new studies were identified on the interaction between omega-3 fatty acids, both over-the- counter and prescription-grade, on the ef…

2558. Environmental, Clinical and Economic Outcomes of Hospital Resources to Prevent Hospital-Acquired Infections (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prevent-hai-draft-report.pdf
      January 16, 2025 - Procurement cost; Cost per procedure/use; Costs for: reprocessing, transportation, storage, functionality testing

2559. Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/vaccine-safety_executive.pdf
      January 01, 2020 - Safety of Vaccines Used for Routine Immunization in the United States Evidence-Based Practice Evidence-based Practice Program The Agency for Healthcare Research and Quality (AHRQ), through its Evidence- based Practice Centers (EPCs), sponsors the development of evidence reports and technology assessments to a…

2560. Linking Dental Services to Treatment Outcomes for Diabetes (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/treatment-outcomes-diabetes-rapid-research.pdf
      July 19, 2024 - Linking Dental Services to Treatment Outcomes for Diabetes 1 Linking Dental Services to Treatment Outcomes for Diabetes A Rapid Response Review Eric Davis1, Courtney Luterbach1, Anupama Reddy1, Jared Brewer1, Esther Avendano2, Elise Digga2, Shayesteh Jahanfar3, Daniel Weiner4, David Leader5, Sa…